(Circulation. 1997;95:701-708.)
© 1997 American Heart Association, Inc.
Articles |
Intracoronary Application of C1 Esterase Inhibitor Improves Cardiac Function and Reduces Myocardial Necrosis in an Experimental Model of Ischemia and Reperfusion
the Johannes Gutenberg-University Mainz, Second Medical Clinic (G.H., O.B., P.B., P.B., H.D., H.J.R., J.M.); the Institute for Neurosurgical Pathophysiology (A.H., O.K.); the Institute for Microbiology and Hygiene (M.L., S.B.); the Institute for Clinical Chemistry (G.H.); and Georg-August-University Gottingen, Department of Immunology (O.G.), Germany.
Correspondence to Dr Georg Horstick, Johannes Gutenberg-University Mainz, Second Medical Clinic, Langenbeckstraße 1, 55101 Mainz, Germany.
Background Myocardial injury from ischemia can be aggravated by reperfusion of the jeopardized area. The precise underlying mechanisms have not been clearly defined, but proinflammatory events, including complement activation, leukocyte adhesion, and infiltration and release of diverse mediators, probably play important roles. The present study addresses the possibility of reducing reperfusion damage by the application of C1 esterase inhibitor (C1-INH).
Methods and Results Cardioprotection by C1-INH 20 IU/kg IC was examined in a pig model with 60 minutes of coronary occlusion, followed by 120 minutes of reperfusion. C1-INH was administered during the first 5 minutes of coronary reperfusion. Compared with the NaCl controls, C1-INH reduced myocardial injury (48.8±7.8% versus 73.4±4.0% necrosis of area at risk, P
.018). C1-INH treatment significantly reduced circulating C3a and slightly attenuated C5a plasma concentrations. Myocardial protection was accompanied by reduced plasma concentration of creatine kinase and troponin-T. C1-INH had no effect on global hemodynamic parameters, but local myocardial contractility was markedly improved in the ischemic zone. In the short-axis view, 137° of the anteroseptal region showed significantly improved wall motion at early and 29° at late reperfusion with C1-INH treatment.
Conclusions C1-INH significantly protects ischemic tissue from reperfusion damage, reduces myocardial necrosis, and improves local cardiac function.
Key Words: myocardial infarction • ischemia • reperfusion • immune system • contractility
This article has been cited by other articles:
 |
|
 |
|
  Y. Banz, O. M. Hess, S. C. Robson, E. Csizmadia, D. Mettler, P. Meier, A. Haeberli, S. Shaw, R. A. Smith, and R. Rieben Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1 Cardiovasc Res, December 1, 2007; 76(3): 482 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liu, F. Lu, G. Qin, S. M. Fernandes, J. Li, and A. E. Davis III C1 Inhibitor-Mediated Protection from Sepsis J. Immunol., September 15, 2007; 179(6): 3966 - 3972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fattouch, G. Bianco, G. Speziale, R. Sampognaro, C. Lavalle, F. Guccione, P. Dioguardi, and G. Ruvolo Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Baig, R. Nassar, D. M. Craig, G. Quick Jr, H. X. Jiang, M. M. Frank, A. J. Lodge, P. A.W. Anderson, and J. Jaggers Complement Factor 1 Inhibitor Improves Cardiopulmonary Function in Neonatal Cardiopulmonary Bypass Ann. Thorac. Surg., April 1, 2007; 83(4): 1477 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Thielmann, G. Marggraf, M. Neuhauser, J. Forkel, U. Herold, M. Kamler, P. Massoudy, and H. Jakob Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 285 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Aletras, G. S. Tilak, A. Natanzon, L.-Y. Hsu, F. M. Gonzalez, R. F. Hoyt Jr, and A. E. Arai Retrospective Determination of the Area at Risk for Reperfused Acute Myocardial Infarction With T2-Weighted Cardiac Magnetic Resonance Imaging: Histopathological and Displacement Encoding With Stimulated Echoes (DENSE) Functional Validations Circulation, April 18, 2006; 113(15): 1865 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Fernandez, J. B. Garcia-Bengochea, J. Alvarez, L. F. Perez, J. M. Suarez, J. Forteza, J. Cortes, and A. Martinez Apical suction leads to severe ischemia of the ventricular apex. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 506 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Natanzon, A. H. Aletras, L.-Y. Hsu, and A. E. Arai Determining Canine Myocardial Area at Risk with Manganese-enhanced MR Imaging Radiology, September 1, 2005; 236(3): 859 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tarnavski, J. R. McMullen, M. Schinke, Q. Nie, S. Kong, and S. Izumo Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies Physiol Genomics, February 13, 2004; 16(3): 349 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Riedemann and P. A. Ward Complement in Ischemia Reperfusion Injury Am. J. Pathol., February 1, 2003; 162(2): 363 - 367. [Full Text] [PDF]
|
|
|
|
|
|
C. de Zwaan, A.H. Kleine, J.H.C. Diris, J.F.C. Glatz, H.J.J. Wellens, P.F.W. Strengers, M. Tissing, C.E. Hack, M.P. van Dieijen-Visser, and W.T. Hermens Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction Eur. Heart J., November 1, 2002; 23(21): 1670 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Horstick, O. Berg, A. Heimann, O. Gotze, M. Loos, G. Hafner, B. Bierbach, S. Petersen, S. Bhakdi, H. Darius, et al. Application of C1-Esterase Inhibitor During Reperfusion of Ischemic Myocardium: Dose-Related Beneficial Versus Detrimental Effects Circulation, December 18, 2001; 104(25): 3125 - 3131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jiang, E. Wagner, H. Zhang, and M. M. Frank Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway J. Exp. Med., December 3, 2001; 194(11): 1609 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Buerke, H. Schwertz, W. Seitz, J. Meyer, and H. Darius Novel Small Molecule Inhibitor of C1s Exerts Cardioprotective Effects in Ischemia-Reperfusion Injury in Rabbits J. Immunol., November 1, 2001; 167(9): 5375 - 5380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bauernschmitt, C. Schreiber, and R. Lange C1 esterase inhibitor concentrate during surgery with cardiopulmonary bypass: Is there an indication beyond substitution therapy in patients with hereditary angioneurotic edema? J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 427 - 428. [Full Text]
|
|
|
|
 |
|
 V. H. Thourani, S. S. Brar, T. P. Kennedy, L. R. Thornton, J. A. Watts, R. S. Ronson, Z.-Q. Zhao, A. L. Sturrock, J. R. Hoidal, and J. Vinten-Johansen Nonanticoagulant heparin inhibits NF-kappa B activation and attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2084 - H2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Human Heart Generates Complement Proteins That Are Upregulated and Activated After Myocardial Infarction Circ. Res., October 19, 1998; 83(8): 860 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Buerke, D. Prüfer, M. Dahm, H. Oelert, J. Meyer, and H. Darius Blocking of Classical Complement Pathway Inhibits Endothelial Adhesion Molecule Expression and Preserves Ischemic Myocardium from Reperfusion Injury J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 429 - 438. [Abstract] [Full Text]
|
|
|
|
|
|
K. Yasojima, K. S. Kilgore, R. A. Washington, B. R. Lucchesi, and P. L. McGeer Complement Gene Expression by Rabbit Heart : Upregulation by Ischemia and Reperfusion Circ. Res., June 15, 1998; 82(11): 1224 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Vakeva, A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy Circulation, June 9, 1998; 97(22): 2259 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]
|
|